Loading…
Loading…
Rithm Capital (RITM) offers a 10% dividend yield, well-covered by earnings, making it compelling for income-focused investors in a high-rate environment. RITM's diversified business model, driven by servicing, residential transitional lending, and investment portfolio segments, differentiates it from traditional mREITs. Elevated interest rates enhance the value of RITM's mortgage servicing rights, but commercial real estate exposure and earnings volatility remain notable risks.
Rithm (RITM) reported earnings 30 days ago. What's next for the stock?
This collection of 37 Dogcatcher LoPrice/HiYield Dogs was found by screening the Russell 3000 list for dividends yielding between 5% and 25%. Here are top-yield small to large-cap stocks priced between $5 and $65 per-share showing hight yields over the past five (or more) years. “To find the best stocks to Buy -now, search for stocks of companies with consistent-profits, good cash-flow and other-indicators that reflect -quality.”--Kiplinger.com/Investing.
Rithm Capital offers the best combination of strong dividend coverage (2.4x) and a substantial discount to book value (~0.82x). Annaly Capital earns a Buy rating for its consistent dividend coverage and improving fundamentals, despite trading above book value and thinner coverage. Dynex Capital and Armour Residential provide higher yields but lack sufficient earnings cushion, making their dividends less attractive relative to risk and valuation.
European Capital Solutions Fund II Exceeds Predecessor by Nearly 75% and Demonstrates Strong Demand for Crestline's Flexible, Partnership-Driven Approach to Value Creation FORT WORTH, Texas, Aug. 20, 2026 /PRNewswire/ -- Crestline Management, L.P. ("Crestline"), a global alternative investment management firm, today announced the final close of Crestline European Capital Solutions Fund II ("ECSFII" or the "Fund") with $625 million in capital commitments, nearly 75 percent larger than Fund I.
Can RITM sustain its 9.6% dividend yield as rising costs and liquidity risks pressure its earnings? Let us discuss.
Is RITM worth buying as its low valuation and broadening earnings base contend with higher expenses, limited liquidity and MSR risks? Let's discuss.
Can RITM sustain its 12.2% one-month gain as asset management growth and Newrez efficiency gains offset liquidity and MSR risks? Let's discuss.